Kareem Zaghloul, MD
Enriched profileSenior Investigator, Functional Neurosurgery Section, Surgical Neurology Branch (SNB), NINDS · National Institutes of Health
Kareem Zaghloul is Senior Investigator, Functional Neurosurgery Section, Surgical Neurology Branch (SNB), NINDS at National Institutes of Health. OpenAlex indexes 301 publications with 9,564 citations (h-index 56); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurological Surgery profiles in the FindMyKOL directory.
Data verified 21 Oct 2026
Overview
Updated 27 Oct 2026
Kareem Zaghloul, MD, is Senior Investigator, Functional Neurosurgery Section, Surgical Neurology Branch (SNB), NINDS at National Institutes of Health (NINDS, Intramural Research Program). The public record shows 301 publications with 9,564 citations (h-index 56), centered on Neural dynamics and brain function, Epilepsy research and treatment, Memory and Neural Mechanisms. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2009–2009).
- Most recent indexed publication: 2026 · Movement disorders
- Top research focus: Neural dynamics and brain function
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 42 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 124.
Clinical & industry
trials, payments and federal fundingContact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Building 10, Room 3D20, 10 Center Drive, Bethesda, MD 20814
Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Study of Direct Brain Recording and Stimulation for Memory Enhancement
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
- Tumor Related Epilepsy
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
- Feasibility Study of Deep Brain Recordings for Learning and Memory
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Industry payments
Updated 26 Oct 2026
4 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Baxter HealthcareProgram year20257 payments
- Brainlab, Inc.Program year20251 payment
- Integra LifeSciences CorporationProgram year20241 payment
NIH funding
Updated 26 Oct 2026
1 NIH research award on record, funded 2009–2009 per NIH RePORTER. The latest:
- Investigating the neural mechanisms of human cognitive function through intracranial recordings
National Institute of Neurological Disorders and Stroke
FY2025$3,928,348ZIANS003144 - Investigating the neural mechanisms of human cognitive function through intracranial recordings
National Institute of Neurological Disorders and Stroke
FY2024$3,956,644ZIANS003144 - Investigating the neural mechanisms of human cognitive function through intracranial recordings
National Institute of Neurological Disorders and Stroke
FY2023$3,120,736ZIANS003144
Congress activity
Updated 26 Oct 2026
3 congress contributions (2020–2023) across ASCO per OpenAlex. The most recent:
- Phase II trial evaluating nivolumab in patients with recurrent IDH-mutant gliomas with and without hypermutation phenotype.
ASCO Annual Meeting
ASCO2023Co-author - First-in-human dose escalation and food effect study of oral ONC206 in adults with recurrent primary CNS neoplasms.
ASCO Annual Meeting
ASCO2021Co-authorPosterTrials in progress - A first-in-human phase I single-agent dose-escalation, food effect and dose expansion study of oral ONC206 in recurrent and rare primary central nervous system neoplasms.
ASCO Annual Meeting
ASCO2020Co-authorPosterTrials in progress
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.
Movement disorders
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Frontosubthalamic Circuits for Control of Action and CognitionArticle291 citations2016
- 03Coupled ripple oscillations between the medial temporal lobe and neocortex retrieve human memoryArticle265 citations2019
- 04Human Substantia Nigra Neurons Encode Unexpected Financial RewardsArticle264 citations2009
- 05Synchronous and Asynchronous Theta and Gamma Activity during Episodic Memory FormationArticle250 citations2013
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Greten, MD
National Institutes of Health
Joel Moss, MD
National Institutes of Health
Lynnette Nieman, MD
National Institutes of Health
Steven Pavletic, MD
National Institutes of Health
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center